Tech Company Financing Transactions
TransMedics Funding Round
On 4/13/2007, TransMedics received $25.5 million in Series D investment from Tudor Ventures, 3i Venture Capital and Alta Partners.
Transaction Overview
Company Name
Announced On
4/13/2007
Transaction Type
Venture Equity
Amount
$25,500,000
Round
Series D
Investors
Proceeds Purpose
The proceeds will be used to fund TransMedics' commercial launch of the Organ Care System� in Europe, complete U.S. clinical trials, and to accelerate the development of the Organ Care System's platform for other organs beyond the heart, such as the lung, liver and kidney.
Company Information
Company Status
Publicly-held
Industry
Medical Devices & Instruments
Mailing Address
200 Minuteman Rd. 302
Andover, MA 01810
USA
Andover, MA 01810
USA
Phone
Website
Email Address
Overview
TransMedics (Nasdaq: TMDX) has developed a revolutionary new system that enables living organ transplants.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Waleed Hassanein
Chief Financial Officer
Stephen Gordon
Chief Medical Officer
Tamer Khayal
Vice President
Jacqueline Sneve
VP - Engineering
John Sullivan
VP - Operations
John Carey
VP - Regulatory Affairs
Miriam Provost
Browse more venture capital transactions:
Prev: 4/13/2007: Collplant venture capital transaction
Next: 4/13/2007: Nanochip venture capital transaction
Share this article
About Database of VC Transactions
We document tech company VC transactions. VC transactions reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs